Assessing the inclusion of postinflammatory hyperpigmentation outcomes in acne vulgaris clinical trials - 01/11/24
Doi : 10.1016/j.jaad.2024.10.004
Alyssa Swearingen, BA a, b, Christine Olagun-Samuel, BA a, Arielle R. Nagler, MD a, Prince Adotama, MD a, ⁎ 
a Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York
b Rutgers New Jersey Medical School, Newark, New Jersey
∗Correspondence to: Prince Adotama, MD, Ronald O. Perelman Department of Dermatology, NYU Langone Health, 240 E 38th St, 12th Floor, New York, NY 10016Ronald O. Perelman Department of DermatologyNYU Langone Health240 E 38th St, 12th FloorNew YorkNY10016
En prensa. Pruebas corregidas por el autor.
Disponible en línea desde el Friday 01 November 2024
Key words : acne-induced hyperpigmentation, acne vulgaris, clinical trials, outcome measures, postinflammatory hyperpigmentation, primary outcomes, secondary outcomes, skin of color
| Authors Swearingen and Olagun-Samuel contributed to this work equally. |
|
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Not applicable. |
© 2024
American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?